FDA Withdrawal Sticks It To Public Citizen’s Needle-Ban Campaign
This article was originally published in The Gray Sheet
Executive Summary
FDA withdrew an advance notice of proposed rulemaking concerning a ban on certain needle-bearing devices and the creation of safety standards, much to the dismay of Public Citizen's Health Research Group
You may also be interested in...
FDA Considers Needlestick Safety Standards For Banning Devices
FDA is soliciting public comment on safety criteria to determine whether to ban certain needlestick devices and create standards aimed at reducing injury risk among health care workers
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.